Switching Medicare Advantage (MA) plans is increasingly common among MA enrollees, especially those dually eligible for ...
A national study found comorbidities may drive worse long-term survival among patients with MASH awaiting or undergoing liver transplant.
The One Big Beautiful Bill Act restructures Medicaid coverage in ways that have a direct impact on oncology programs. This ...
1. ZANVASTRO (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) ...
Patients with ≥5 impaired domains experienced markedly worse outcomes versus none, including >2-fold higher mortality and ...
John R. Hurst, MD, PhD, explains how BEAM-302 gene editing targets both lung and liver disease in alpha-1 antitrypsin ...
Francesca Puggioni, MD, explains how multidisciplinary teams choose COPD biologics and why systemic inflammation matters as much as FEV1. Multidisciplinary approaches, particularly when treating ...